Bluejay Diagnostics (NASDAQ:BJDX) Posts Quarterly Earnings Results

Bluejay Diagnostics (NASDAQ:BJDX) announced its quarterly earnings results on Monday. The company reported ($112.37) EPS for the quarter, Zacks reports.

Bluejay Diagnostics Stock Down 1.0 %

NASDAQ BJDX opened at $3.58 on Wednesday. The stock has a market capitalization of $1.98 million, a PE ratio of 0.00 and a beta of 0.38. Bluejay Diagnostics has a 12-month low of $3.03 and a 12-month high of $316.92. The company has a 50 day moving average price of $3.84 and a two-hundred day moving average price of $4.46.

Bluejay Diagnostics Company Profile

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.